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The bacteriumNocardia terpenica IFM 0406 is known as the producer of the immunosuppressant brasilicardin A. Here, we re-
port the completely sequenced genome of strain IFM 0406, which facilitates the heterologous expression of the brasilicardin bio-
synthetic gene cluster but also unveils the intriguing biosynthetic capacity of the strain to produce secondary metabolites.
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Actinobacteria of the genus Nocardia are often found to behuman and animal pathogens that cause pulmonary, cutane-
ous and subcutaneous diseases (1–3). However, species in this
genus also produce a plethora of potent bioactive natural com-
pounds with therapeutic potential. For example, Nocardia ter-
penica IFM 0406 (formerly referred to as Nocardia brasiliensis IFM
0406) is known to produce the antifungal and immunosuppres-
sant brasilinolides A–C (4, 5) and brasilicardins AD (6–9). The
immunosuppressant brasilicardin A is of particular interest be-
cause its potency is superior to today’s standard immunosuppres-
sive drugs for organ transplantation, but it is less toxic, since it
mediates its activity by a different mode of action (10). The devel-
opment of this promising lead structure is currently hampered
due to supply issues. The producer strain only shows a low pro-
duction titer and is furthermore categorized as a biosafety-level 2
organism. Both of these facts make the fermentative production of
brasilicardin A expensive and elaborate. Due to its complex stere-
ochemistry, a total synthesis has not been achieved to date (11–
13). Therefore, we want to overcome this hurdle by heterologous
expression of the corresponding biosynthetic gene cluster (14) in a
nonpathogenic producer strain. In order to obtain the full biosyn-
thetic pathway, including the related precursor metabolic path-
ways, we sequenced the genome of N. terpenica IFM 0406.
Genome sequencing was carried out using the Illumina HiSeq
2500 and Pacific Biosciences RS II sequencing platforms.
Genomic DNA was isolated (ZR fungal/bacterial DNA mini prep
kit, Zymo Research) and a paired-end library with bar coding was
constructed (Nextera DNA sample preparation kit). The HiSeq
paired-end data were processed and filtered, and a quality analysis
was performed. This resulted in 6,564,821 reads with an average
length of 509 bp (approx. 360 coverage). The quality of the
Illumina FASTQ sequences was enhanced by trimming off low-
quality bases, which was followed by de novo assembly using CLC
Genomics Workbench version 7.0.4 to yield contigs. The optimal
k-mer size was determined using KmerGenie (15). In addition, a
10-kb genomic sublibrary of strain IFM 0406 was produced and
sequenced with PacBioSMRT technology. The resultant continu-
ous long-read (CLR) data were filtered using the SMRT Analysis
software suite. In summary, one run produced 113,652 filtered
reads with average read lengths of 3,262 bp (approx. 40 cover-
age). The contigs were linked and placed into super-scaffolds
based on the alignment of the PacBio CLR reads using BLASR (16)
and SSPACE-LongRead scaffolder version 7.0.4 (17). The gapped
regions within the super-scaffolds were closed using GapFiller
version 1.10 (18).
The final gap-closed genome comprises three scaffolds with a
total size of 9,276,856 bp and a GC content of 68.5%. The ge-
nome contains 8,755 open reading frames, including 76 tRNA
genes and nine rRNA operons. Bioinformatic analyses using anti-
SMASH version 3.0 (19) revealed that IFM 0406 possessed, besides
the putative brasilicardin (14) and brasilinolide (20) gene cluster, 47
further orphan natural product biosynthesis gene clusters. Insight
into the genome of strain IFM 0406 not only reveals a high potential
to produce secondary metabolites, but will also enable and facilitate
the heterologous expression and biotechnological production of bra-
silicardins in a nonpathogenic host system.
Accession number(s). This genome sequence has been de-
posited in EMBL/GenBank under the accession number
crossmark
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LWGR00000000. The version described in this paper is the first
version.
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